Loading, please wait ...

News Analytics

VIACYTE LOGO jpg?p=facebook.
SAN DIEGO, Sept. 13, 2021 /PRNewswire/ -- , an innovator in cellular therapy and regenerative medicine, today announced the appointment of Timothy Kieffer, Ph.D., as Chief Scientific Officer. Dr. Kieffer will bring his deep knowledge of gene and cell therapies, regenerative medicine, diabetes applied research, and industry experience to lead ViaCyte's scientific team focused on delivering and commercializing clinical interventions for diabetes.

The Angle

Subject Matter

  • Science and technology 64.56%
  • Healthcare 35.44%
    • Hospitals, doctors and medical care 100.00%

Emotional Reaction






Depth Chart

Here we provide depth for the multitude of dimensions lacing this article.

Connect your favorite information below with the lead sentence at the top of the page to build a mental model of the story.